title: Cerebral MRI is necessary in patients with rheumatoid arthritis and uveitis before undergoing therapy with TNF-alpha blocking agents.
authors.affiliation: Volker.Limmroth@uni-essen.de
authors.forename: V
authors.initials: V
authors.lastname: Limmroth
authors.forename: C
authors.initials: C
authors.lastname: Thimm
authors.forename: T
authors.initials: T
authors.lastname: Hudde
authors.forename: T
authors.initials: T
authors.lastname: Fuchsluger
authors.forename: I
authors.initials: I
authors.lastname: Wanke
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004660:Encephalitis / Q000139:chemically induced / Q000175:diagnosis*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014605:Uveitis / Q000150:complications*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha